165879-74-3

Usage

Uses

Used in Pharmaceutical Industry:
((2R,5S)-tetrahydrofuran-2,5-diyl)bis(Methylene) bis(4-Methylbenzenesulfonate) is used as a building block in the synthesis of organic compounds for its potential pharmaceutical applications. Its unique structure allows it to be a key component in the development of new drugs and therapeutic agents.
Used in Polymer Production:
In the polymer industry, ((2R,5S)-tetrahydrofuran-2,5-diyl)bis(Methylene) bis(4-Methylbenzenesulfonate) is used as a reagent in chemical reactions to produce a variety of polymers and materials. Its properties contribute to the creation of polymers with specific characteristics, making it valuable in this field.
Used in Organic Synthesis:
((2R,5S)-tetrahydrofuran-2,5-diyl)bis(Methylene) bis(4-Methylbenzenesulfonate) is utilized as a reagent in organic synthesis, where it aids in the formation of complex organic molecules. Its role in these reactions is crucial for the production of various organic compounds used in different applications.

Upstream product

• 104-80-3 tetrahydrofuran-2,5-dimethanol 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 54746-12-2 3-phenyl-8-oxa-3-aza-bicyclo[3.2.1]octane 
• 90883-55-9 2,5-bis<<2-(2-hydroxyethoxy)phenoxy>methyl>tetrahydrofuran 

Relevant academic research and scientific papers

MORPHOLINE-BRIDGED INDAZOLE DERIVATIVES

The invention relates to novel morpholine-bridged indazole derivatives which stimulate soluble guanylate cyclase, to methods for the production thereof and to the use of the same for producing medicaments, especially medicaments for treating diseases of the central nervous system.

NOVEL 2,5-DISUBSTITUTED PYRIMIDINE DERIVATIVES

The invention relates to novel 2,5-disubstituted pyrimidine derivatives, which stimulate the soluble guanylate cyclase, method for production and use thereof for the production of medicaments, in particular medicaments for the treatment of central nervous system diseases.

8-Oxa-3-azabicyclo(3.2.1)octane analgesic compositions and method of alleviating pain in animals

Disclosed are compounds, having the following general formula, which are useful as analgesics in living animals. SPC1 Wherein R is a radical selected from the group consisting of aralkyl, aryl, aminoalkyl, arylalkanoyl, heteroaroyl, alkoxy substituted aroyl, alkenyl (C2 to C4), halogen substituted aralkyl, guanadinoalkyl, halogen substituted aroyl, alkyl substituted aroyl, halogen substituted arylalkanoyl, hexahydrobenzoyl, arylalkenoyl, o- or p-alkyl substituted phenylalkanoyl, alkyl substituted naphthylalkanoyl, alkanoyl (C3 to C20), haloalkyl substituted aroyl, alkoxy substituted aralkyl, heteroaralkyl, anilinocarbonyl, adamantanecarbonyl, arylsulfonyl, carboxyl substituted aroyl, hydroxyl substituted aroyl, alkanoyloxy substituted aroyl, arylglyoxylyl, alicyclic, arylene dicarbonyl-8-oxa-3-azabicyclo(3.2.1)octane, alkylene-8-oxa-3-azabicyclo (3.2.1)octane, alkylene dicarbonyl-8-oxa-3-azabicyclo(3.2.1)octane, and the pharmacologically acceptable acid addition salts thereof.